Fractyl Health, Inc. financial data

Symbol
GUTS on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
3 Van De Graaff Drive, Suite 200, Burlington, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Fractyl Laboratories Inc. (to 3/19/2020)
Latest financial report
10-K - Q4 2024 - Mar 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 619 %
Quick Ratio 0.45 %
Debt-to-equity 133 %
Return On Equity -118 % -553%
Return On Assets -50.4 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.9M shares +2.14%
Common Stock, Shares, Outstanding 48.8M shares +2215%
Entity Public Float 144M USD
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 43.5M shares +1992%
Weighted Average Number of Shares Outstanding, Diluted 43.5M shares +1992%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 50K USD -35.1%
Research and Development Expense 70.5M USD +85.3%
Operating Income (Loss) -93.5M USD -84%
Nonoperating Income (Expense) 24.8M USD
Net Income (Loss) Attributable to Parent -68.7M USD +10.9%
Earnings Per Share, Basic -1.62 USD/shares +96.4%
Earnings Per Share, Diluted -1.62 USD/shares +96.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 67.5M USD +103%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Inventory, Net 73K USD 0%
Assets, Current 71.8M USD +101%
Property, Plant and Equipment, Net 2.98M USD +508%
Operating Lease, Right-of-Use Asset 28.4M USD -6.17%
Other Assets, Noncurrent 666K USD -88%
Assets 108M USD +41.8%
Accounts Payable, Current 3.24M USD +486%
Liabilities, Current 19.8M USD +76.8%
Operating Lease, Liability, Noncurrent 27.4M USD -3.95%
Other Liabilities, Noncurrent 998K USD
Liabilities 79.7M USD -30.1%
Retained Earnings (Accumulated Deficit) -415M USD -19.8%
Stockholders' Equity Attributable to Parent 28.4M USD
Liabilities and Equity 108M USD +41.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.7M USD -22.6%
Net Cash Provided by (Used in) Financing Activities 101M USD
Net Cash Provided by (Used in) Investing Activities -1.06M USD -5195%
Common Stock, Shares Authorized 300M shares +180%
Common Stock, Shares, Issued 48.8M shares +2215%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 88.2M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 71.7M USD +89.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 621K USD
Deferred Tax Assets, Valuation Allowance 120M USD +24.5%
Deferred Tax Assets, Gross 127M USD +22%
Operating Lease, Liability 32.3M USD
Depreciation 53K USD -33.8%
Payments to Acquire Property, Plant, and Equipment 1.06M USD +5195%
Lessee, Operating Lease, Liability, to be Paid 56.7M USD
Property, Plant and Equipment, Gross 4.57M USD -14%
Operating Lease, Liability, Current 4.96M USD +81.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.41M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 5.25M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 24.4M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.57M USD
Deferred Tax Assets, Operating Loss Carryforwards 68.9M USD +10.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.74M USD
Additional Paid in Capital 444M USD +1959%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 14.4M USD +236%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%